Editor’s note: This quiz is the first in a 2-part series on GOLD COPD Report recommendations.

In part 1 of the COPD Stakeholder Summit, a panel of experts about the burden of COPD, available treatments, and more. Today, we are bringing you part 1 of a 2-part podcast series discussing chronic ...

Although most Medicare Part D plans cover guideline-recommended outpatient chronic obstructive pulmonary disease (COPD) inhalers, the utilization controls applied to these therapies vary by plan type.

An inpatient COPD care pathway embedded in the EHR was linked to shorter hospital stays, lower costs, more pulmonary ...

Inhaled bronchodilators can be useful in patients with COPD, even when spirometry testing before and after acute bronchodilator therapy does not show a significant (> 10%) response. [23] Long-acting ...

The arrival of cold weather can exacerbate the condition, causing difficulty in breathing due to airway irritation, pollution ...

Pulmatrix Presents Top Line Clinical Data Showing Inhaled Drug Candidate, PUR118, Demonstrated Anti-Inflammatory Efficacy In Phase 1b Trial with COPD Patients , Inc., a clinical stage biotechnology ...

COPD, which includes chronic bronchitis and emphysema, is progressive, meaning it gets worse over time without treatment.

Cigarette smoking is the cause of 80%-90% of COPD in the United States. The most effective method to prevent COPD is to avoid cigarette smoking. Efforts to prevent cigarette smoking need to be ...